# Rege Nephro

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rege-nephro

- Industry: Biotechnology
- Headquarters: Kyoto, Japan
- Website: www.regenephro.co.jp
- Total disclosed funding: $17M
- Latest round: Series B (Oct 7, 2024)
- Investors on record: 26

## About

Rege Nephro Co., Ltd., d.b.a. Rege Nephro, was founded in 2019 and operates out of Kyoto, Japan. The company focuses on developing regenerative medical products. In July 2021, Rege Nephro raised JPY 480 million in venture funding from TaiAn Technologies. Rege Nephro specializes in advanced regenerative technologies aimed at addressing various health and wellness challenges. The company’s core offerings encompass innovative solutions designed to enhance cellular regeneration and promote recovery in patients. These products serve various end-user segments, including healthcare providers, rehabilitation centers, and individual consumers seeking improved health outcomes. The company has strategically targeted markets in Japan and select regions in Asia, where it has established a robust client base focused on therapeutic interventions. Rege Nephro generates revenue through a combination of B2B partnerships and direct-to-consumer sales channels. The company’s business transactions typically involve healthcare institutions purchasing regenerative products for clinical applications, alongside retail sales to consumers interested in personal health enhancements. Pricing structures are established around individual product lines, which include flagship regenerative therapies marketed to both healthcare professionals and end-users. Through these channels, the company effectively reaches its target markets, ensuring a steady flow of revenue from both institutional clients and consumers seeking health solutions. The company plans to use the July 2026 funds to advance clinical preparation and development of its kidney disease treatment and regenerative medicine programs, while supporting future licensing efforts, research activities, and hiring.

## Funding rounds

- Series B, Oct 7, 2024, $1.7M — Daiwa Corporate Investment, Nippon Venture Capital, JAFCO Group, Industrial Technology Investment Corporation, Mitsubishi UFJ Capital, Global Brain, Senshu Ikeda Capital, TOHOKU University Venture Partners, Kyoto University Innovation Capital, QB Capital, SCREEN Holdings Co., Ltd., Shimadzu Corporation, Asahi Kasei Corporate Venture Capital, Investment Lab(VC), JIC Venture Growth Investments, Toyo Seikan Group Holdings, Ltd.
- Series A, Jan 31, 2022, $12M — JAFCO Group, Mitsubishi UFJ Capital, SMBC Venture Capital, Asahi Kasei Corporation, M3, Inc., Chushin Venture Capital, Kyoto University Innovation Capital, DM Capital, Kyoto Capital Partners, Healthcare Innovation, Shimadzu Corporation, Yamu Overseas
- Series A, Jun 4, 2020, $3.3M — JAFCO Group, Fujifilm Holdings Corporation, Japan Science and Technology Agency, Kyoto University Innovation Capital, Kyoto Capital Partners

## Investors

- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series A, Series B
- Fujifilm Holdings Corporation — Series A
- Japan Science and Technology Agency — Series A
- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Series A, Series B
- Kyoto Capital Partners (https://capitalatlas.ai/funds/kyoto-capital-partners) — Series A
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series A, Series B
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series A
- Asahi Kasei Corporation — Series A
- M3, Inc. — Series A
- Chushin Venture Capital (https://capitalatlas.ai/funds/chushin-venture-capital) — Series A
- DM Capital — Series A
- Healthcare Innovation — Series A
- Shimadzu Corporation — Series A, Series B
- Yamu Overseas — Series A
- Daiwa Corporate Investment (https://capitalatlas.ai/funds/daiwa-corporate-investment) — Series B
- Nippon Venture Capital (https://capitalatlas.ai/funds/nippon-venture-capital) — Series B
- Industrial Technology Investment Corporation (https://capitalatlas.ai/funds/industrial-technology-investment-corporation) — Series B
- Global Brain (https://capitalatlas.ai/funds/global-brain) — Series B
- Senshu Ikeda Capital (https://capitalatlas.ai/funds/senshu-ikeda-capital) — Series B
- TOHOKU University Venture Partners (https://capitalatlas.ai/funds/tohoku-university-venture-partners) — Series B
- QB Capital (https://capitalatlas.ai/funds/qb-capital) — Series B
- SCREEN Holdings Co., Ltd. — Series B
- Asahi Kasei Corporate Venture Capital — Series B
- Investment Lab(VC) — Series B
- JIC Venture Growth Investments (https://capitalatlas.ai/funds/jic-venture-growth-investments) — Series B
- Toyo Seikan Group Holdings, Ltd. — Series B